Nocturnal Enuresis Epidemiology Forecast

DelveInsight's 'Nocturnal Enuresis - Epidemiology Forecast to 2030' report delivers an in-depth understanding of the disease, historical and forecasted Nocturnal Enuresis epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.


Geographies Covered

  • The United States
  • EU5 (Germany, France, Italy, Spain, and the United Kingdom)
  • Japan


Study Period: 2017-2030


Nocturnal Enuresis Understanding

The DelveInsight Nocturnal Enuresis epidemiology report gives a thorough understanding of the Nocturnal Enuresis by including details such as disease definition, symptoms, causes, pathophysiology, and diagnosis. It also provides treatment algorithms and treatment guidelines for Nocturnal Enuresis in the US, Europe, and Japan. The report covers the detailed information of the Nocturnal Enuresis epidemiology scenario in seven major countries (US, EU5, and Japan).


Nocturnal Enuresis Epidemiology Perspective by DelveInsight

The Nocturnal Enuresis epidemiology division provides insights about historical and current patient pool and forecasted trend for every seven major countries. The Nocturnal Enuresis epidemiology data are studied through all possible division to give a better understanding of the Disease scenario in 7MM. The Nocturnal Enuresis epidemiology segment covers the epidemiology data in the US, EU5 countries (Germany, Spain, Italy, France, and the UK), and Japan from 2017 to 2030. It also helps to recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.


Nocturnal Enuresis Detailed Epidemiology Segmentation

The Nocturnal Enuresis epidemiology covered in the report provides historical as well as forecasted Nocturnal Enuresis epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom) and Japan from 2017 to 2030.

The DelveInsight Nocturnal Enuresis report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.


Scope of the Report

  • The Nocturnal Enuresis report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
  • The Nocturnal Enuresis Epidemiology Report and Model provide an overview of the risk factors and global trends of Nocturnal Enuresis in the seven major markets (7MM:US, France, Germany, Italy, Spain, UK, and Japan)
  • The report provides insight about the historical and forecasted patient pool of Nocturnal Enuresis in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan
  • The report helps to recognize the growth opportunities in the 7MM with respect to the patient population
  • The report assesses the disease risk and burden and highlights the unmet needs of Nocturnal Enuresis
  • The report provides the segmentation of the Nocturnal Enuresis epidemiology


Report Highlights

  • 11-Year Forecast of Nocturnal Enuresis epidemiology
  • 7MM Coverage
  • Total Cases of Nocturnal Enuresis
  • Total Cases of Nocturnal Enuresis according to segmentation
  • Diagnosed cases of Nocturnal Enuresis


KOL- Views

We interview, KOLs and SME's opinion through primary research to fill the data gaps and validate our secondary research. The opinion helps to understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.


Key Questions Answered

  • What will be the growth opportunities in the 7MM with respect to the patient population pertaining to Nocturnal Enuresis?
  • What are the key findings pertaining to the Nocturnal Enuresis epidemiology across 7MM and which country will have the highest number of patients during the forecast period (2017-2030)?
  • What would be the total number of patients of Nocturnal Enuresis across the 7MM during the forecast period (2017-2030)?
  •  Among the EU5 countries, which country will have the highest number of patients during the forecast period (2017-2030)?
  • At what CAGR the patient population is expected to grow in 7MM during the forecast period (2017-2030)?
  • What is the disease risk, burden and unmet needs of the Nocturnal Enuresis?
  • What are the currently available treatments of Nocturnal Enuresis?


Reasons to buy

  • The Nocturnal Enuresis Epidemiology report will allow the user to -
  • Develop business strategies by understanding the trends shaping and driving the global Nocturnal Enuresis market
  • Quantify patient populations in the global Nocturnal Enuresis market to improve product design, pricing, and launch plans
  • Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Nocturnal Enuresis therapeutics in each of the markets covered
  • Understand the magnitude of Nocturnal Enuresis population by its epidemiology
  • The Nocturnal Enuresis Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over 11-year forecast period using reputable sources


Key Assessments

  • Patient Segmentation
  • Disease Risk and Burden
  • Risk of disease by the segmentation
  • Factors driving growth in a specific patient population

1. Key Insights 

2. Executive Summary of Nocturnal Enuresis

3. Nocturnal Enuresis: Disease Background and Overview

3.1. Introduction

3.2. Sign and Symptoms

3.3. Pathophysiology

3.4. Risk Factors

3.5. Diagnosis

4. Patient Journey

5. Epidemiology and Patient Population

5.1. Epidemiology Key Findings

5.2. Assumptions and Rationale: 7MM

5.3. Epidemiology Scenario: 7MM

5.3.1. Nocturnal Enuresis Epidemiology Scenario in the 7MM (2017- 2030)

5.4. United States Epidemiology

5.4.1. Nocturnal Enuresis Epidemiology Scenario in the United States (2017- 2030)

5.5. EU-5 Country-wise Epidemiology

5.5.1. Germany Epidemiology

5.5.1.1. Nocturnal Enuresis Epidemiology Scenario in Germany (2017- 2030)

5.5.2. France Epidemiology

5.5.2.1. Nocturnal Enuresis Epidemiology Scenario in France (2017- 2030)

5.5.3. Italy Epidemiology

5.5.3.1. Nocturnal Enuresis Epidemiology Scenario in Italy (2017- 2030)

5.5.4. Spain Epidemiology

5.5.4.1. Nocturnal Enuresis Epidemiology Scenario in Spain (2017- 2030)

5.5.5. United Kingdom Epidemiology

5.5.5.1. Nocturnal Enuresis Epidemiology Scenario in the United Kingdom (2017-2030)

5.6. Japan Epidemiology

5.6.1. Nocturnal Enuresis Epidemiology Scenario in Japan (2017- 2030)

6. Treatment Algorithm, Current Treatment, and Medical Practices

6.1. Nocturnal Enuresis Treatment and Management

6.2. Nocturnal Enuresis Treatment Algorithm

7. KOL Views

8. Unmet Needs

9.  Appendix

9.1. Bibliography

9.2. Report Methodology

10. DelveInsight Capabilities

11. Disclaimer

12. About DelveInsight

*The table of contents is not exhaustive; will be provided in the final report

Table 1  Nocturnal Enuresis Epidemiology in 7MM (2017-2030)

Table 2 Nocturnal Enuresis Diagnosed and Treatable Cases in 7MM (2017-2030)

Table 3 Nocturnal Enuresis Epidemiology in the United States (2017-2030)

Table 4 Nocturnal Enuresis Diagnosed and Treatable Cases in the United States (2017-2030)

Table 5 Nocturnal Enuresis Epidemiology in Germany (2017-2030)

Table 6 Nocturnal Enuresis Diagnosed and Treatable Cases in Germany (2017-2030)

Table 7 Nocturnal Enuresis Epidemiology in France (2017-2030)

Table 8 Nocturnal Enuresis Diagnosed and Treatable Cases in France (2017-2030)

Table 9 Nocturnal Enuresis Epidemiology in Italy (2017-2030)

Table 10 Nocturnal Enuresis Diagnosed and Treatable Cases in Italy (2017-2030)

Table 11 Nocturnal Enuresis Epidemiology in Spain (2017-2030)

Table 12 Nocturnal Enuresis Diagnosed and Treatable Cases in Spain (2017-2030)

Table 13 Nocturnal Enuresis Epidemiology in the United Kingdom (2017-2030)

Table 14 Nocturnal Enuresis Diagnosed and Treatable Cases in the United Kingdom (2017-2030)

Table 15 Nocturnal Enuresis Epidemiology in Japan (2017-2030)

Table 16 Nocturnal Enuresis Diagnosed and Treatable Cases in Japan (2017-2030)

Figure 1 Nocturnal Enuresis Epidemiology in 7MM (2017-2030)

Figure 2 Nocturnal Enuresis Diagnosed and Treatable Cases in 7MM (2017-2030)

Figure 3 Nocturnal Enuresis Epidemiology in the United States (2017-2030)

Figure 4 Nocturnal Enuresis Diagnosed and Treatable Cases in the United States (2017-2030)

Figure 5 Nocturnal Enuresis Epidemiology in Germany (2017-2030)

Figure 6 Nocturnal Enuresis Diagnosed and Treatable Cases in Germany (2017-2030)

Figure 7 Nocturnal Enuresis Epidemiology in France (2017-2030)

Figure 8 Nocturnal Enuresis Diagnosed and Treatable Cases in France (2017-2030)

Figure 9 Nocturnal Enuresis Epidemiology in Italy (2017-2030)

Figure 10 Nocturnal Enuresis Diagnosed and Treatable Cases in Italy (2017-2030)

Figure 11 Nocturnal Enuresis Epidemiology in Spain (2017-2030)

Figure 12 Nocturnal Enuresis Diagnosed and Treatable Cases in Spain (2017-2030)

Figure 13 Nocturnal Enuresis Epidemiology in the United Kingdom (2017-2030)

Figure 14 Nocturnal Enuresis Diagnosed and Treatable Cases in the United Kingdom (2017-2030)

Figure 15 Nocturnal Enuresis Epidemiology in Japan (2017-2030)

Figure 16 Nocturnal Enuresis Diagnosed and Treatable Cases in Japan (2017-2030)

*The table of contents is not exhaustive; will be provided in the final report



  • Tags:
  • Nocturnal Enuresis Epidemiology
  • Nocturnal Enuresis
  • Nocturnal Enuresis Pipeline
  • Nocturnal Enuresis Companies
  • Nocturnal Enuresis prevalent popul...
  • Nocturnal Enuresis incident popula...
  • Nocturnal Enuresis patients diagno...
  • Nocturnal Enuresis treatment algor...

Forward to Friend

Need A Quote